Literature DB >> 8870793

Application of glutamate in the cortex of rats: a microdialysis study.

B Alessandri1, H Landolt, H Langemann, J Gregorin, J Hall, O Gratzl.   

Abstract

Glutamate, a major neurotransmitter in the brain, is also involved in pathophysiological processes resulting in secondary lesions following ischaemia or trauma. In the present study we investigated the relationship between glutamate excitotoxicity free radical induction (indicated by ascorbic acid level) and glucose-lactate metabolism. Monosodium glutamate was applied through microdialysis probes (500 mM in perfusate) into the cortex of rats for 30 minutes and ascorbic acid (ASC), glucose (GLUC) and lactate (LAC) were measured in dialysates. Glutamate produced a cortical lesion with an average volume of 12.7 +/- 1.4 mm3. Analysis of dialysates revealed a significant increase of ASC (325 +/- 52% of baseline) and LAC (677 +/- 86%) in the core lesion. In the lesion periphery a non-significant and short-lasting elevation was measured for both parameters with a second microdialysis probe (about 1.3 mm frontally to the first probe). A concomitant decrease of GLUC was found in both probes, reaching 29 +/- 8% and 60 +/- 7% of basal levels in the core and periphery of the lesion, respectively. In addition, we studied the delivery characteristics of several glutamate concentrations (10, 100 or 1000 mM in perfusate) during a 90-minute application into the cortex. The delivery of glutamate from the perfusate to the brain was about 33-38% in the first 30 min and afterwards 11 25% of the total in the perfusate. The results show that cortical application of glutamate changes the composition of the extracellular fluid, which could contribute to the development of the lesion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870793     DOI: 10.1007/978-3-7091-6894-3_2

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  8 in total

1.  Opposing muscarinic and nicotinic modulation of hypoglossal motor output to genioglossus muscle in rats in vivo.

Authors:  Xia Liu; Sandeep Sood; Hattie Liu; Richard L Horner
Journal:  J Physiol       Date:  2005-04-07       Impact factor: 5.182

2.  Microdialysis perfusion of 5-HT into hypoglossal motor nucleus differentially modulates genioglossus activity across natural sleep-wake states in rats.

Authors:  A Jelev; S Sood; H Liu; P Nolan; R L Horner
Journal:  J Physiol       Date:  2001-04-15       Impact factor: 5.182

3.  Simultaneous inhibition of caudal medullary raphe and retrotrapezoid nucleus decreases breathing and the CO2 response in conscious rats.

Authors:  Aihua Li; Shawn Zhou; Eugene Nattie
Journal:  J Physiol       Date:  2006-07-06       Impact factor: 5.182

Review 4.  Endocannabinoids and traumatic brain injury.

Authors:  Esther Shohami; Ayelet Cohen-Yeshurun; Lital Magid; Merav Algali; Raphael Mechoulam
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

5.  Metabolic and histologic effects of sodium pyruvate treatment in the rat after cortical contusion injury.

Authors:  Masamichi Fukushima; Stefan M Lee; Nobuhiro Moro; David A Hovda; Richard L Sutton
Journal:  J Neurotrauma       Date:  2009-07       Impact factor: 5.269

6.  D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window.

Authors:  Amos Adeleye; Esther Shohami; Dean Nachman; Alexander Alexandrovich; Victoria Trembovler; Rami Yaka; Yigal Shoshan; Jasbeer Dhawan; Anat Biegon
Journal:  Eur J Pharmacol       Date:  2009-12-01       Impact factor: 4.432

Review 7.  Can lactate serve as an energy substrate for axons in good times and in bad, in sickness and in health?

Authors:  Selva Baltan
Journal:  Metab Brain Dis       Date:  2014-07-19       Impact factor: 3.584

8.  Inhibition of NR2B phosphorylation restores alterations in NMDA receptor expression and improves functional recovery following traumatic brain injury in mice.

Authors:  Johanna Schumann; G Alexander Alexandrovich; Anat Biegon; Rami Yaka
Journal:  J Neurotrauma       Date:  2008-08       Impact factor: 5.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.